Literature DB >> 12235250

Nociceptin/orphanin FQ modulation of ionic conductances in rat basal forebrain neurons.

J H Chin1, K Harris, D MacTavish, J H Jhamandas.   

Abstract

Nociceptin/orphanin FQ (N/OFQ) is an endogenous opioid-like heptadecapeptide that plays an important role in a variety of physiological functions. N/OFQ and its receptor opioid receptor-like orphan receptor-1 are abundant in the diagonal band of Broca (DBB), a basal forebrain nucleus where the loss of cholinergic neurons is linked to memory and spatial learning deficits. In the whole animal, central injections of N/OFQ have been shown to disrupt spatial learning. In this study, we investigated the basis for these behavioral observations by examining the cellular effects of N/OFQ on chemically identified DBB neurons. Whole cell patch-clamp recordings were performed on enzymatically dissociated DBB neurons. Under voltage-clamp conditions, bath application of N/OFQ (10 pM-1 microM) resulted in a dose-dependent depression of whole cell currents. Single cell reverse transcription-polymerase chain reaction analysis identified cholinergic and fewer GABAergic cells to be N/OFQ-responsive. [Nphe(1)]nociceptin-(1-13)-NH(2) and CompB (J-113397) antagonized the N/OFQ response, but both compounds also displayed partial agonist activity. Using a combination of channel blockers we determined that the effects of N/OFQ were mediated via a suite of Ca(2+) (N- and L-type) and Ca(2+)-dependent K(+) (iberiotoxin-sensitive) conductances. In addition, biophysical analysis of voltage subtraction protocols revealed that N/OFQ reduces transient outward and the delayed rectifier K(+) currents. Because N-type and L-type Ca(2+) channels are important in the context of neurotransmitter release, our observations indicate that N/OFQ inhibition of Ca(2+)-dependent conductances in cholinergic neurons would be expected to result in depression of acetylcholine release, which may explain the behavioral actions of N/OFQ in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235250     DOI: 10.1124/jpet.102.037945

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and tolerance.

Authors:  Lynn C Hull; Christopher Rabender; Bichoy H Gabra; Fan Zhang; Pin-Lan Li; William L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

2.  Orphanin FQ antagonizes the inhibition of Ca(2+) currents induced by mu-opioid receptors.

Authors:  Min Zhang; Xiaomin Wang; Dabao Zhang; Guoheng Xu; Hongwei Dong; Yingxin Yu; Jisheng Han
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Roles of K+ and cation channels in ORL-1 receptor-mediated depression of neuronal excitability and epileptic activities in the medial entorhinal cortex.

Authors:  Huiming Li; Binqi Hu; Hao-Peng Zhang; Cody A Boyle; Saobo Lei
Journal:  Neuropharmacology       Date:  2019-04-15       Impact factor: 5.250

4.  The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism.

Authors:  Miwako Koizumi; Kazuto Sakoori; Naoko Midorikawa; Niall P Murphy
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

Review 5.  Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.

Authors:  Jong Yung Park; Suji Chae; Chang Seop Kim; Yoon Jae Kim; Hyun Joo Yi; Eunjoo Han; Youngshin Joo; Surim Hong; Jae Won Yun; Hyojung Kim; Kyung Ho Shin
Journal:  Korean J Physiol Pharmacol       Date:  2019-10-24       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.